Authors:
Devereux, HL
Burke, A
Lee, CA
Johnson, MA
Citation: Hl. Devereux et al., In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution, J MED VIROL, 66(1), 2002, pp. 8-12
Authors:
Webber, SE
Marakovits, JT
Dragovich, PS
Prins, TJ
Zhou, R
Fuhrman, SA
Patick, AK
Matthews, DA
Lee, CA
Srinivasan, B
Moran, T
Ford, CE
Brothers, MA
Harr, JEV
Meador, JW
Ferre, RA
Worland, ST
Citation: Se. Webber et al., Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 11(20), 2001, pp. 2683-2686
Citation: Lm. Schechter et Ca. Lee, AraC/XylS family members, HilC and HilD, directly bind and derepress the Salmonella typhimurium hilA promoter, MOL MICROB, 40(6), 2001, pp. 1289-1299
Authors:
Nitu-Whalley, IC
Griffioen, A
Harrington, C
Lee, CA
Citation: Ic. Nitu-whalley et al., Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease, AM J HEMAT, 66(4), 2001, pp. 280-284
Citation: Ic. Nitu-whalley et al., Reassessment of the correlation between the von Willebrand factor activity, the PFA-100((R)), and the bleeding time in patients with von Willebrand disease, THROMB HAEM, 86(2), 2001, pp. 715-716
Authors:
Zhang, KYE
Hee, B
Lee, CA
Liang, BH
Potts, BCM
Citation: Kye. Zhang et al., Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease, DRUG META D, 29(5), 2001, pp. 729-734
Authors:
Loftin, CD
Trivedi, DB
Tiano, HF
Clark, JA
Lee, CA
Epstein, JA
Morham, SG
Breyer, MD
Nguyen, M
Hawkins, BM
Goulet, JL
Smithies, O
Koller, BH
Langenbach, R
Citation: Cd. Loftin et al., Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2, P NAS US, 98(3), 2001, pp. 1059-1064
Authors:
Sabin, CA
Lepri, AC
Devereux, H
Phillips, AN
Loveday, C
Lee, CA
Citation: Ca. Sabin et al., Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia, J INFEC DIS, 184(4), 2001, pp. 511-514
Citation: Wl. Chan et al., Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes, J IMMUNOL, 167(3), 2001, pp. 1238-1244
Citation: Rl. Lucas et Ca. Lee, Roles of hilC and hilD in regulation of hilA expression in Salmonella enterica serovar typhimurium, J BACT, 183(9), 2001, pp. 2733-2745
Citation: Cp. Lostroh et Ca. Lee, The HilA, box and sequences outside it determine the magnitude of HilA-dependent activation of P-prgH from Salmonella pathogenicity island 1, J BACT, 183(16), 2001, pp. 4876-4885
Citation: Ah. Miners et al., Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?, J INTERN M, 247(4), 2000, pp. 493-499
Citation: Cp. Lostroh et al., The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1, MOL MICROB, 37(2), 2000, pp. 300-315
Citation: Rl. Lucas et Ca. Lee, Unravelling the mysteries of virulence gene regulation in Salmonella typhimurium, MOL MICROB, 36(5), 2000, pp. 1024-1033
Authors:
Nitu-Whalley, IC
Riddell, A
Lee, CA
Pasi, KJ
Owens, D
Enayat, MS
Perkins, SJ
Jenkins, PV
Citation: Ic. Nitu-whalley et al., Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients. a reappraisal using phenotypes, genotypes and molecular modelling, THROMB HAEM, 84(6), 2000, pp. 998-1004